ALT 0 3 0 3 B-clinical_variable
and 4 7 4 7 I-clinical_variable
AST 8 11 8 11 I-clinical_variable
= 12 13 12 13 O
< 13 14 13 14 O
5 15 16 15 16 B-upper_bound
times 17 22 17 22 I-upper_bound
the 23 26 23 26 I-upper_bound
institutional 27 40 27 40 I-upper_bound
upper 41 46 41 46 I-upper_bound
limits 47 53 47 53 I-upper_bound
of 54 56 54 56 I-upper_bound
normal 57 63 57 63 I-upper_bound

ARM 0 3 64 67 O
2 4 5 68 69 O
- 6 7 70 71 O
BPDCN 8 13 72 77 B-cancer
: 13 14 77 78 O
Research 15 23 79 87 O
participants 24 36 88 100 O
with 37 41 101 105 O
a 42 43 106 107 O
diagnosis 44 53 108 117 O
of 54 56 118 120 O
BPDCN 57 62 121 126 O
, 62 63 126 127 O
according 64 73 128 137 O
to 74 76 138 140 O
World 77 82 141 146 O
Health 83 89 147 153 O
Organization 90 102 154 166 O
( 103 104 167 168 O
WHO 104 107 168 171 O
) 107 108 171 172 O
classification 109 123 173 187 O
by 124 126 188 190 O
hematopathology 127 142 191 206 O
, 142 143 206 207 O
who 144 147 208 211 O
underwent 148 157 212 221 O
at 158 160 222 224 O
least 161 166 225 230 O
1 167 168 231 232 B-lower_bound
line 169 173 233 237 O
of 174 176 238 240 O
systemic 177 185 241 249 B-treatment
therapy 186 193 250 257 I-treatment
for 194 197 258 261 O
BPDCN 198 203 262 267 O
and 204 207 268 271 O
who 208 211 272 275 O
have 212 216 276 280 O
persistent 217 227 281 291 O
or 228 230 292 294 O
recurrent 231 240 295 304 O
disease 241 248 305 312 O

AST 0 3 313 316 B-clinical_variable
= 4 5 317 318 O
< 5 6 318 319 O
5 7 8 320 321 B-upper_bound
x 9 10 322 323 I-upper_bound
ULN 11 14 324 327 I-upper_bound
, 14 15 327 328 O
ALT 16 19 329 332 B-clinical_variable
= 20 21 333 334 O
< 21 22 334 335 O
5 23 24 336 337 O
x 25 26 338 339 O
ULN 27 30 340 343 O

Active 0 6 344 350 O
autoimmune 7 17 351 361 B-chronic_disease
disease 18 25 362 369 I-chronic_disease
requiring 26 35 370 379 O
systemic 36 44 380 388 B-treatment
immunosuppressive 45 62 389 406 I-treatment
therapy 63 70 407 414 I-treatment

Alanine 0 7 415 422 B-clinical_variable
aminotransferase 8 24 423 439 I-clinical_variable
( 25 26 440 441 I-clinical_variable
ALT 26 29 441 444 I-clinical_variable
) 29 30 444 445 I-clinical_variable
and 31 34 446 449 O
aspartate 35 44 450 459 B-clinical_variable
aminotransferase 45 61 460 476 I-clinical_variable
( 62 63 477 478 I-clinical_variable
AST 63 66 478 481 I-clinical_variable
) 66 67 481 482 I-clinical_variable
= 68 69 483 484 O
< 69 70 484 485 O
5 71 72 486 487 B-upper_bound
times 73 78 488 493 I-upper_bound
the 79 82 494 497 I-upper_bound
institutional 83 96 498 511 I-upper_bound
upper 97 102 512 517 I-upper_bound
limits 103 109 518 524 I-upper_bound
of 110 112 525 527 I-upper_bound
normal 113 119 528 534 I-upper_bound

All 0 3 535 538 O
research 4 12 539 547 O
participants 13 25 548 560 O
must 26 30 561 565 O
have 31 35 566 570 O
the 36 39 571 574 O
ability 40 47 575 582 O
to 48 50 583 585 O
understand 51 61 586 596 O
and 62 65 597 600 O
willingness 66 77 601 612 O
to 78 80 613 615 O
sign 81 85 616 620 O
a 86 87 621 622 O
written 88 95 623 630 O
informed 96 104 631 639 O
consent 105 112 640 647 O
or 113 115 648 650 O
age 116 119 651 654 B-age
appropriate 120 131 655 666 O
assent 132 138 667 673 O
for 139 142 674 677 O
pediatric 143 152 678 687 O
patients 153 161 688 696 O

CD123 0 5 697 702 O
positivity 6 16 703 713 O
must 17 21 714 718 O
be 22 24 719 721 O
confirmed 25 34 722 731 O
by 35 37 732 734 O
either 38 44 735 741 O
flow 45 49 742 746 B-treatment
cytometry 50 59 747 756 I-treatment
or 60 62 757 759 O
immunohistochemistry 63 83 760 780 B-treatment
prior 84 89 781 786 O
to 90 92 787 789 O
start 93 98 790 795 O
of 99 101 796 798 O
lymphodepletion 102 117 799 814 B-treatment

CD123 0 5 815 820 O
positivity 6 16 821 831 O
must 17 21 832 836 O
be 22 24 837 839 O
confirmed 25 34 840 849 O
by 35 37 850 852 O
either 38 44 853 859 O
flow 45 49 860 864 O
cytometry 50 59 865 874 B-clinical_variable
or 60 62 875 877 O
immunohistochemistry 63 83 878 898 B-clinical_variable
within 84 90 899 905 O
90 91 93 906 908 B-upper_bound
days 94 98 909 913 I-upper_bound
of 99 101 914 916 O
study 102 107 917 922 O
entry 108 113 923 928 O

Calculated 0 10 929 939 B-clinical_variable
creatinine 11 21 940 950 I-clinical_variable
clearance 22 31 951 960 I-clinical_variable
( 32 33 961 962 O
absolute 33 41 962 970 O
value 42 47 971 976 O
) 47 48 976 977 O
of 49 51 978 980 O
> 52 53 981 982 O
= 53 54 982 983 O
50 55 57 984 986 B-lower_bound
mL 58 60 987 989 I-lower_bound
/ 60 61 989 990 I-lower_bound
minute 61 67 990 996 I-lower_bound
or 68 70 997 999 O
creatinine 71 81 1000 1010 O
< 82 83 1011 1012 O
2.0 84 87 1013 1016 B-upper_bound
mg 88 90 1017 1019 I-upper_bound
/ 90 91 1019 1020 I-upper_bound
dl 91 93 1020 1022 I-upper_bound
or 94 96 1023 1025 O
< 97 98 1026 1027 O
2 99 100 1028 1029 B-upper_bound
times 101 106 1030 1035 I-upper_bound
upper 107 112 1036 1041 I-upper_bound
limit 113 118 1042 1047 I-upper_bound
of 119 121 1048 1050 I-upper_bound
normal 122 128 1051 1057 I-upper_bound
for 129 132 1058 1061 O
the 133 136 1062 1065 O
research 137 145 1066 1074 O
participant 146 157 1075 1086 O
's 157 159 1086 1088 O
age 160 163 1089 1092 B-age
group 164 169 1093 1098 O

Cardiovascular 0 14 1099 1113 O
: 14 15 1113 1114 O
not 16 19 1115 1118 O
requiring 20 29 1119 1128 O
pressor 30 37 1129 1136 O
support 38 45 1137 1144 O
, 45 46 1144 1145 O
no 47 49 1146 1148 O
symptomatic 50 61 1149 1160 O
cardiac 62 69 1161 1168 O
arrhythmias 70 81 1169 1180 B-chronic_disease
, 81 82 1180 1181 O
no 83 85 1182 1184 O
acute 86 91 1185 1190 B-chronic_disease
coronary 92 100 1191 1199 I-chronic_disease
syndrome 101 109 1200 1208 I-chronic_disease
, 109 110 1208 1209 O
or 111 113 1210 1212 O
uncontrolled 114 126 1213 1225 B-chronic_disease
hypertension 127 139 1226 1238 I-chronic_disease

Ejection 0 8 1239 1247 B-clinical_variable
fraction 9 17 1248 1256 I-clinical_variable
measured 18 26 1257 1265 O
by 27 29 1266 1268 O
echocardiogram 30 44 1269 1283 B-treatment
( 45 46 1284 1285 I-treatment
ECHO 46 50 1285 1289 I-treatment
) 50 51 1289 1290 I-treatment
or 52 54 1291 1293 O
multi 55 60 1294 1299 B-treatment
gated 61 66 1300 1305 I-treatment
acquisition 67 78 1306 1317 I-treatment
scan 79 83 1318 1322 I-treatment
( 84 85 1323 1324 I-treatment
MUGA 85 89 1324 1328 I-treatment
) 89 90 1328 1329 I-treatment
> 91 92 1330 1331 O
= 92 93 1331 1332 O
50 94 96 1333 1335 B-lower_bound
% 96 97 1335 1336 I-lower_bound

For 0 3 1337 1340 O
both 4 8 1341 1345 O
related 9 16 1346 1353 O
and 17 20 1354 1357 O
unrelated 21 30 1358 1367 O
donors 31 37 1368 1374 O
: 37 38 1374 1375 O
The 39 42 1376 1379 O
donor 43 48 1380 1385 O
's 48 50 1385 1387 O
hepatitis 51 60 1388 1397 B-chronic_disease
B 61 62 1398 1399 I-chronic_disease
surface 63 70 1400 1407 O
antigen 71 78 1408 1415 O
must 79 83 1416 1420 O
be 84 86 1421 1423 O
negative 87 95 1424 1432 O
and 96 99 1433 1436 O
the 100 103 1437 1440 O
hepatitis 104 113 1441 1450 B-chronic_disease
C 114 115 1451 1452 I-chronic_disease
antibody 116 124 1453 1461 O
must 125 129 1462 1466 O
be 130 132 1467 1469 O
nonreactive 133 144 1470 1481 O

For 0 3 1482 1485 O
research 4 12 1486 1494 O
participants 13 25 1495 1507 O
who 26 29 1508 1511 O
do 30 32 1512 1514 B-language_fluency
not 33 36 1515 1518 I-language_fluency
speak 37 42 1519 1524 I-language_fluency
English 43 50 1525 1532 I-language_fluency
, 50 51 1532 1533 O
a 52 53 1534 1535 O
short 54 59 1536 1541 O
form 60 64 1542 1546 O
consent 65 72 1547 1554 O
may 73 76 1555 1558 O
be 77 79 1559 1561 O
used 80 84 1562 1566 O
with 85 89 1567 1571 O
a 90 91 1572 1573 O
City 92 96 1574 1578 O
of 97 99 1579 1581 O
Hope 100 104 1582 1586 O
( 105 106 1587 1588 O
COH 106 109 1588 1591 O
) 109 110 1591 1592 O
certified 111 120 1593 1602 O
interpreter 121 132 1603 1614 O
/ 132 133 1614 1615 O
translator 133 143 1615 1625 O
to 144 146 1626 1628 O
proceed 147 154 1629 1636 O
with 155 159 1637 1641 O
screening 160 169 1642 1651 O
and 170 173 1652 1655 O
leukapheresis 174 187 1656 1669 O
, 187 188 1669 1670 O
while 189 194 1671 1676 O
the 195 198 1677 1680 O
request 199 206 1681 1688 O
for 207 210 1689 1692 O
a 211 212 1693 1694 O
translated 213 223 1695 1705 O
full 224 228 1706 1710 O
consent 229 236 1711 1718 O
is 237 239 1719 1721 O
processed 240 249 1722 1731 O

He 0 2 1732 1734 O
/ 2 3 1734 1735 O
she 3 6 1735 1738 O
has 7 10 1739 1742 O
undergone 11 20 1743 1752 O
prior 21 26 1753 1758 B-treatment
alloSCT 27 34 1759 1766 I-treatment
, 34 35 1766 1767 O
they 36 40 1768 1772 O
must 41 45 1773 1777 O
be 46 48 1778 1780 O
at 49 51 1781 1783 O
least 52 57 1784 1789 O
2 58 59 1790 1791 B-lower_bound
weeks 60 65 1792 1797 I-lower_bound
from 66 70 1798 1802 O
having 71 77 1803 1809 O
received 78 86 1810 1818 O
the 87 90 1819 1822 O
last 91 95 1823 1827 O
dose 96 100 1828 1832 O
of 101 103 1833 1835 O
immunosuppressant 104 121 1836 1853 B-treatment
medications 122 133 1854 1865 I-treatment
to 134 136 1866 1868 O
undergo 137 144 1869 1876 O
PBMC 145 149 1877 1881 O
collection 150 160 1882 1892 O
for 161 164 1893 1896 O
T 165 166 1897 1898 O
cell 167 171 1899 1903 O
manufacturing 172 185 1904 1917 O

His 0 3 1918 1921 O
/ 3 4 1921 1922 O
her 4 7 1922 1925 O
last 8 12 1926 1930 O
dose 13 17 1931 1935 O
of 18 20 1936 1938 O
prior 21 26 1939 1944 B-treatment
chemotherapy 27 39 1945 1957 I-treatment
, 39 40 1957 1958 O
immunotherapy 41 54 1959 1972 B-treatment
or 55 57 1973 1975 O
radiation 58 67 1976 1985 B-treatment
is 68 70 1986 1988 O
at 71 73 1989 1991 O
least 74 79 1992 1997 O
2 80 81 1998 1999 B-lower_bound
weeks 82 87 2000 2005 I-lower_bound
out 88 91 2006 2009 O
from 92 96 2010 2014 O
PBMC 97 101 2015 2019 O
collection 102 112 2020 2030 O

History 0 7 2031 2038 O
of 8 10 2039 2041 O
allergic 11 19 2042 2050 O
reactions 20 29 2051 2060 O
attributed 30 40 2061 2071 O
to 41 43 2072 2074 O
compounds 44 53 2075 2084 O
of 54 56 2085 2087 O
similar 57 64 2088 2095 O
chemical 65 73 2096 2104 O
or 74 76 2105 2107 O
biological 77 87 2108 2118 O
composition 88 99 2119 2130 O
to 100 102 2131 2133 O
cetuximab 103 112 2134 2143 B-allergy_name

In 0 2 2144 2146 O
the 3 6 2147 2150 O
case 7 11 2151 2155 O
of 12 14 2156 2158 O
a 15 16 2159 2160 O
related 17 24 2161 2168 O
donor 25 30 2169 2174 O
: 30 31 2174 2175 O
The 32 35 2176 2179 O
identified 36 46 2180 2190 O
donor 47 52 2191 2196 O
must 53 57 2197 2201 O
be 58 60 2202 2204 O
the 61 64 2205 2208 O
original 65 73 2209 2217 O
donor 74 79 2218 2223 O
whose 80 85 2224 2229 O
stem 86 90 2230 2234 O
cells 91 96 2235 2240 O
were 97 101 2241 2245 O
used 102 106 2246 2250 O
for 107 110 2251 2254 O
the 111 114 2255 2258 O
research 115 123 2259 2267 O
participant 124 135 2268 2279 O
's 135 137 2279 2281 O
allogeneic 138 148 2282 2292 B-treatment
stem 149 153 2293 2297 I-treatment
cell 154 158 2298 2302 I-treatment
transplantation 159 174 2303 2318 I-treatment
( 175 176 2319 2320 I-treatment
alloSCT 176 183 2320 2327 I-treatment
) 183 184 2327 2328 I-treatment

Infectious 0 10 2329 2339 B-chronic_disease
diseases 11 19 2340 2348 I-chronic_disease
: 19 20 2348 2349 O
no 21 23 2350 2352 O
clinical 24 32 2353 2361 O
evidence 33 41 2362 2370 O
of 42 44 2371 2373 O
uncontrolled 45 57 2374 2386 O
active 58 64 2387 2393 O
infectious 65 75 2394 2404 O
process 76 83 2405 2412 O

Karnofsky 0 9 2413 2422 B-clinical_variable
performance 10 21 2423 2434 I-clinical_variable
status 22 28 2435 2441 I-clinical_variable
( 29 30 2442 2443 I-clinical_variable
KPS 30 33 2443 2446 I-clinical_variable
) 33 34 2446 2447 I-clinical_variable
> 35 36 2448 2449 O
= 36 37 2449 2450 O
70 38 40 2451 2453 B-lower_bound

Karnofsky 0 9 2454 2463 B-clinical_variable
performance 10 21 2464 2475 I-clinical_variable
status 22 28 2476 2482 I-clinical_variable
score 29 34 2483 2488 I-clinical_variable
> 35 36 2489 2490 O
= 36 37 2490 2491 O
70 38 40 2492 2494 B-lower_bound

Liver 0 5 2495 2500 O
Function 6 14 2501 2509 O
: 14 15 2509 2510 O
adequate 16 24 2511 2519 O
liver 25 30 2520 2525 O
function 31 39 2526 2534 O
defined 40 47 2535 2542 O
as 48 50 2543 2545 O
total 51 56 2546 2551 B-clinical_variable
bilirubin 57 66 2552 2561 I-clinical_variable
= 67 68 2562 2563 O
< 68 69 2563 2564 O
3.0 70 73 2565 2568 B-upper_bound
mg 74 76 2569 2571 I-upper_bound
/ 76 77 2571 2572 I-upper_bound
dl 77 79 2572 2574 I-upper_bound

Negative 0 8 2575 2583 B-pregnancy
serum 9 14 2584 2589 I-pregnancy
or 15 17 2590 2592 I-pregnancy
urine 18 23 2593 2598 I-pregnancy
pregnancy 24 33 2599 2608 I-pregnancy
test 34 38 2609 2613 O

Neurological 0 12 2614 2626 O
: 12 13 2626 2627 O
research 14 22 2628 2636 O
participant 23 34 2637 2648 O
without 35 42 2649 2656 O
clinically 43 53 2657 2667 O
significant 54 65 2668 2679 O
encephalopathy 66 80 2680 2694 B-chronic_disease
/ 80 81 2694 2695 O
new 81 84 2695 2698 O
focal 85 90 2699 2704 B-chronic_disease
deficits 91 99 2705 2713 I-chronic_disease

Non 0 3 2714 2717 O
hematological 4 17 2718 2731 O
toxicity 18 26 2732 2740 O
related 27 34 2741 2748 O
to 35 37 2749 2751 O
prior 38 43 2752 2757 B-treatment
therapy 44 51 2758 2765 I-treatment
must 52 56 2766 2770 O
either 57 63 2771 2777 O
have 64 68 2778 2782 O
returned 69 77 2783 2791 O
to 78 80 2792 2794 O
= 81 82 2795 2796 O
< 82 83 2796 2797 O
grade 84 89 2798 2803 B-upper_bound
2 90 91 2804 2805 I-upper_bound
, 91 92 2805 2806 O
baseline 93 101 2807 2815 O
, 101 102 2815 2816 O
or 103 105 2817 2819 O
deemed 106 112 2820 2826 O
irreversible 113 125 2827 2839 O

ONLY 0 4 2840 2844 O
research 5 13 2845 2853 O
participants 14 26 2854 2866 O
experiencing 27 39 2867 2879 O
hypoxia 40 47 2880 2887 B-chronic_disease
with 48 52 2888 2892 O
oxygen 53 59 2893 2899 B-clinical_variable
saturation 60 70 2900 2910 I-clinical_variable
less 71 75 2911 2915 O
than 76 80 2916 2920 O
92 81 83 2921 2923 B-upper_bound
% 83 84 2923 2924 I-upper_bound
are 85 88 2925 2928 O
required 89 97 2929 2937 O
to 98 100 2938 2940 O
have 101 105 2941 2945 O
diffusion 106 115 2946 2955 O
capacity 116 124 2956 2964 O
of 125 127 2965 2967 O
carbon 128 134 2968 2974 O
monoxide 135 143 2975 2983 O
( 144 145 2984 2985 O
DLCO 145 149 2985 2989 O
) 149 150 2989 2990 O
or 151 153 2991 2993 O
forced 154 160 2994 3000 B-clinical_variable
expiratory 161 171 3001 3011 I-clinical_variable
volume 172 178 3012 3018 I-clinical_variable
in 179 181 3019 3021 I-clinical_variable
one 182 185 3022 3025 I-clinical_variable
second 186 192 3026 3032 I-clinical_variable
( 193 194 3033 3034 I-clinical_variable
FEV1 194 198 3034 3038 I-clinical_variable
) 198 199 3038 3039 I-clinical_variable
> 200 201 3040 3041 O
45 202 204 3042 3044 B-lower_bound
% 204 205 3044 3045 I-lower_bound
predicted 206 215 3046 3055 O

Pediatric 0 9 3056 3065 O
research 10 18 3066 3074 O
participants 19 31 3075 3087 O
must 32 36 3088 3092 O
weigh 37 42 3093 3098 B-clinical_variable
> 43 44 3099 3100 O
50 45 47 3101 3103 B-lower_bound
kg 48 50 3104 3106 I-lower_bound

Pregnant 0 8 3107 3115 B-pregnancy

Pulmonary 0 9 3116 3125 O
: 9 10 3125 3126 O
not 11 14 3127 3130 O
requiring 15 24 3131 3140 O
supplemental 25 37 3141 3153 B-treatment
oxygen 38 44 3154 3160 I-treatment
or 45 47 3161 3163 O
mechanical 48 58 3164 3174 B-treatment
ventilation 59 70 3175 3186 I-treatment
, 70 71 3186 3187 O
oxygen 72 78 3188 3194 B-clinical_variable
saturation 79 89 3195 3205 I-clinical_variable
90 90 92 3206 3208 B-lower_bound
% 92 93 3208 3209 I-lower_bound
or 94 96 3210 3212 O
higher 97 103 3213 3219 O
on 104 106 3220 3222 O
room 107 111 3223 3227 O
air 112 115 3228 3231 O

Refractory 0 10 3232 3242 O
AML 11 14 3243 3246 B-cancer
is 15 17 3247 3249 O
defined 18 25 3250 3257 O
as 26 28 3258 3260 O
patients 29 37 3261 3269 O
that 38 42 3270 3274 O
have 43 47 3275 3279 O
not 48 51 3280 3283 O
achieved 52 60 3284 3292 O
a 61 62 3293 3294 O
first 63 68 3295 3300 O
CR 69 71 3301 3303 O
after 72 77 3304 3309 O
2 78 79 3310 3311 O
cycles 80 86 3312 3318 O
of 87 89 3319 3321 O
induction 90 99 3322 3331 O
chemotherapy 100 112 3332 3344 B-treatment

Relapsed 0 8 3345 3353 B-cancer
AML 9 12 3354 3357 I-cancer
is 13 15 3358 3360 O
defined 16 23 3361 3368 O
as 24 26 3369 3371 O
patients 27 35 3372 3380 O
that 36 40 3381 3385 O
had 41 44 3386 3389 O
a 45 46 3390 3391 O
first 47 52 3392 3397 O
complete 53 61 3398 3406 O
remission 62 71 3407 3416 O
( 72 73 3417 3418 O
CR 73 75 3418 3420 O
) 75 76 3420 3421 O
before 77 83 3422 3428 O
developing 84 94 3429 3439 O
recurrent 95 104 3440 3449 O
disease 105 112 3450 3457 O
( 113 114 3458 3459 O
increased 114 123 3459 3468 O
bone 124 128 3469 3473 O
marrow 129 135 3474 3480 O
blasts 136 142 3481 3487 O
) 142 143 3487 3488 O

Related 0 7 3489 3496 O
donor 8 13 3497 3502 O
selection 14 23 3503 3512 O
will 24 28 3513 3517 O
be 29 31 3518 3520 O
conducted 32 41 3521 3530 O
in 42 44 3531 3533 O
accordance 45 55 3534 3544 O
with 56 60 3545 3549 O
City 61 65 3550 3554 O
of 66 68 3555 3557 O
Hope 69 73 3558 3562 O
's 73 75 3562 3564 O
Department 76 86 3565 3575 O
of 87 89 3576 3578 O
Hematology 90 100 3579 3589 O
& 101 102 3590 3591 O
Hematopoietic 103 116 3592 3605 B-treatment
Cell 117 121 3606 3610 I-treatment
Transplantation 122 137 3611 3626 I-treatment
criteria 138 146 3627 3635 O
and 147 150 3636 3639 O
, 150 151 3639 3640 O
in 152 154 3641 3643 O
the 155 158 3644 3647 O
case 159 163 3648 3652 O
of 164 166 3653 3655 O
unrelated 167 176 3656 3665 O
donor 177 182 3666 3671 O
from 183 187 3672 3676 O
a 188 189 3677 3678 O
transplant 190 200 3679 3689 O
center 201 207 3690 3696 O
, 207 208 3696 3697 O
will 209 213 3698 3702 O
comply 214 220 3703 3709 O
with 221 225 3710 3714 O
the 226 229 3715 3718 O
National 230 238 3719 3727 O
Marrow 239 245 3728 3734 O
Donor 246 251 3735 3740 O
Program 252 259 3741 3748 O
's 259 261 3748 3750 O
( 262 263 3751 3752 O
NMDP 263 267 3752 3756 O
) 267 268 3756 3757 O
donor 269 274 3758 3763 O
selection 275 284 3764 3773 O
standards 285 294 3774 3783 O

Renal 0 5 3784 3789 O
Function 6 14 3790 3798 O
: 14 15 3798 3799 O
calculated 16 26 3800 3810 B-clinical_variable
creatinine 27 37 3811 3821 I-clinical_variable
clearance 38 47 3822 3831 I-clinical_variable
( 48 49 3832 3833 O
absolute 49 57 3833 3841 O
value 58 63 3842 3847 O
) 63 64 3847 3848 O
of 65 67 3849 3851 O
> 68 69 3852 3853 O
= 69 70 3853 3854 O
50 71 73 3855 3857 B-lower_bound
mL 74 76 3858 3860 I-lower_bound
/ 76 77 3860 3861 I-lower_bound
minute 77 83 3861 3867 I-lower_bound
or 84 86 3868 3870 O
creatinine 87 97 3871 3881 O
< 98 99 3882 3883 O
2.0 100 103 3884 3887 B-upper_bound
mg 104 106 3888 3890 I-upper_bound
/ 106 107 3890 3891 I-upper_bound
dl 107 109 3891 3893 I-upper_bound
or 110 112 3894 3896 O
< 113 114 3897 3898 O
2 115 116 3899 3900 B-upper_bound
times 117 122 3901 3906 I-upper_bound
upper 123 128 3907 3912 I-upper_bound
limit 129 134 3913 3918 I-upper_bound
of 135 137 3919 3921 I-upper_bound
normal 138 144 3922 3928 I-upper_bound
for 145 148 3929 3932 O
the 149 152 3933 3936 O
research 153 161 3937 3945 O
participant 162 173 3946 3957 O
's 173 175 3957 3959 O
age 176 179 3960 3963 B-age
group 180 185 3964 3969 O

Renal 0 5 3970 3975 O
Function 6 14 3976 3984 O
: 14 15 3984 3985 O
serum 16 21 3986 3991 B-clinical_variable
creatinine 22 32 3992 4002 I-clinical_variable
did 33 36 4003 4006 O
NOT 37 40 4007 4010 O
increase 41 49 4011 4019 O
by 50 52 4020 4022 O
more 53 57 4023 4027 O
than 58 62 4028 4032 O
2.5 63 66 4033 4036 B-lower_bound
fold 67 71 4037 4041 O
from 72 76 4042 4046 O
baseline 77 85 4047 4055 O
( 86 87 4056 4057 O
at 87 89 4057 4059 O
time 90 94 4060 4064 O
of 95 97 4065 4067 O
screening 98 107 4068 4077 O
) 107 108 4077 4078 O

Research 0 8 4079 4087 O
participant 9 20 4088 4099 O
has 21 24 4100 4103 O
> 25 26 4104 4105 O
= 26 27 4105 4106 O
1 28 29 4107 4108 B-lower_bound
% 29 30 4108 4109 I-lower_bound
CAR 31 34 4110 4113 B-clinical_variable
T 35 36 4114 4115 I-clinical_variable
cells 37 42 4116 4121 I-clinical_variable
in 43 45 4122 4124 O
the 46 49 4125 4128 O
peripheral 50 60 4129 4139 O
blood 61 66 4140 4145 O

Research 0 8 4146 4154 O
participant 9 20 4155 4166 O
has 21 24 4167 4170 O
a 25 26 4171 4172 O
released 27 35 4173 4181 O
cryopreserved 36 49 4182 4195 B-treatment
T 50 51 4196 4197 I-treatment
cell 52 56 4198 4202 I-treatment
product 57 64 4203 4210 I-treatment
for 65 68 4211 4214 O
CAR 69 72 4215 4218 B-treatment
T 73 74 4219 4220 I-treatment
cell 75 79 4221 4225 I-treatment
infusion 80 88 4226 4234 I-treatment
on 89 91 4235 4237 O
approximately 92 105 4238 4251 O
day 106 109 4252 4255 O
0 110 111 4256 4257 O

Research 0 8 4258 4266 O
participant 9 20 4267 4278 O
must 21 25 4279 4283 O
be 26 28 4284 4286 O
at 29 31 4287 4289 O
least 32 37 4290 4295 O
2 38 39 4296 4297 B-lower_bound
weeks 40 45 4298 4303 I-lower_bound
out 46 49 4304 4307 O
from 50 54 4308 4312 O
having 55 61 4313 4319 O
received 62 70 4320 4328 O
the 71 74 4329 4332 O
last 75 79 4333 4337 O
dose 80 84 4338 4342 O
of 85 87 4343 4345 O
investigational 88 103 4346 4361 B-treatment
agent 104 109 4362 4367 I-treatment

Research 0 8 4368 4376 O
participant 9 20 4377 4388 O
must 21 25 4389 4393 O
be 26 28 4394 4396 O
off 29 32 4397 4400 O
all 33 36 4401 4404 O
anti 37 41 4405 4409 B-treatment
- 41 42 4409 4410 I-treatment
leukemic 42 50 4410 4418 I-treatment
drugs 51 56 4419 4424 I-treatment

Research 0 8 4425 4433 O
participant 9 20 4434 4445 O
with 21 25 4446 4450 O
central 26 33 4451 4458 O
nervous 34 41 4459 4466 O
system 42 48 4467 4473 O
( 49 50 4474 4475 O
CNS 50 53 4475 4478 O
) 53 54 4478 4479 O
leukemic 55 63 4480 4488 O
involvement 64 75 4489 4500 O
that 76 80 4501 4505 O
is 81 83 4506 4508 O
refractory 84 94 4509 4519 O
to 95 97 4520 4522 O
intrathecal 98 109 4523 4534 B-treatment
chemotherapy 110 122 4535 4547 I-treatment
and/or 123 129 4548 4554 O
cranio 130 136 4555 4561 B-treatment
- 136 137 4561 4562 I-treatment
spinal 137 143 4562 4568 I-treatment
radiation 144 153 4569 4578 I-treatment
but 154 157 4579 4582 O
effectively 158 169 4583 4594 O
treated 170 177 4595 4602 O
to 178 180 4603 4605 O
completion 181 191 4606 4616 O
remission 192 201 4617 4626 O
( 202 203 4627 4628 O
< 203 204 4628 4629 O
5 205 206 4630 4631 B-upper_bound
white 207 212 4632 4637 B-clinical_variable
blood 213 218 4638 4643 I-clinical_variable
cell[WBC]/mm^3 219 233 4644 4658 I-clinical_variable
and 234 237 4659 4662 O
no 238 240 4663 4665 O
blast 241 246 4666 4671 O
in 247 249 4672 4674 O
cerebrospinal 250 263 4675 4688 O
fluid 264 269 4689 4694 O
[ 270 271 4695 4696 O
CSF 271 274 4696 4699 O
] 274 275 4699 4700 O
) 275 276 4700 4701 O
is 277 279 4702 4704 O
eligible 280 288 4705 4713 O
to 289 291 4714 4716 O
proceed 292 299 4717 4724 O
with 300 304 4725 4729 O
lymphodepletion 305 320 4730 4745 B-treatment

Research 0 8 4746 4754 O
participants 9 21 4755 4767 O
has 22 25 4768 4771 O
undergone 26 35 4772 4781 O
lymphodepletion 36 51 4782 4797 B-cancer

Research 0 8 4798 4806 O
participants 9 21 4807 4819 O
must 22 26 4820 4824 O
have 27 31 4825 4829 O
a 32 33 4830 4831 O
donor 34 39 4832 4837 O
or 40 42 4838 4840 O
stem 43 47 4841 4845 O
cells 48 53 4846 4851 O
source 54 60 4852 4858 O
identified 61 71 4859 4869 O
for 72 75 4870 4873 O
allogeneic 76 86 4874 4884 B-treatment
transplantation 87 102 4885 4900 I-treatment
, 102 103 4900 4901 O
either 104 110 4902 4908 O
related 111 118 4909 4916 O
( 119 120 4917 4918 O
7/8 120 123 4918 4921 B-lower_bound
or 124 126 4922 4924 O
8/8 127 130 4925 4928 B-upper_bound
allele 131 137 4929 4935 I-upper_bound
matched 138 145 4936 4943 O
or 146 148 4944 4946 O
haploidentical 149 163 4947 4961 B-treatment
) 163 164 4961 4962 O
, 164 165 4962 4963 O
unrelated 166 175 4964 4973 O
7/8 176 179 4974 4977 O
or 180 182 4978 4980 O
8/8 183 186 4981 4984 O
allele 187 193 4985 4991 O
match 194 199 4992 4997 O
) 199 200 4997 4998 O
donor 201 206 4999 5004 O
, 206 207 5004 5005 O
or 208 210 5006 5008 O
cord 211 215 5009 5013 O
blood 216 221 5014 5019 O
stem 222 226 5020 5024 O
cell 227 231 5025 5029 O
source 232 238 5030 5036 O
( 239 240 5037 5038 O
at 240 242 5038 5040 O
lease 243 248 5041 5046 O
4/6 249 252 5047 5050 B-lower_bound
matched 253 260 5051 5058 O
) 260 261 5058 5059 O

Research 0 8 5060 5068 O
participants 9 21 5069 5081 O
must 22 26 5082 5086 O
have 27 31 5087 5091 O
bone 32 36 5092 5096 O
marrow 37 43 5097 5103 O
and/or 44 50 5104 5110 O
peripheral 51 61 5111 5121 O
blood 62 67 5122 5127 O
samples 68 75 5128 5135 O
available 76 85 5136 5145 O
for 86 89 5146 5149 O
confirmation 90 102 5150 5162 O
of 103 105 5163 5165 O
diagnosis 106 115 5166 5175 O
of 116 118 5176 5178 O
AML 119 122 5179 5182 B-cancer
or 123 125 5183 5185 O
BPDCN 126 131 5186 5191 B-cancer

Research 0 8 5192 5200 O
participants 9 21 5201 5213 O
of 22 24 5214 5216 O
reproductive 25 37 5217 5229 O
potential 38 47 5230 5239 O
must 48 52 5240 5244 O
agree 53 58 5245 5250 B-contraception_consent
to 59 61 5251 5253 I-contraception_consent
use 62 65 5254 5257 I-contraception_consent
and 66 69 5258 5261 I-contraception_consent
utilize 70 77 5262 5269 I-contraception_consent
and 78 81 5270 5273 I-contraception_consent
adequate 82 90 5274 5282 I-contraception_consent
method 91 97 5283 5289 I-contraception_consent
of 98 100 5290 5292 I-contraception_consent
contraception 101 114 5293 5306 I-contraception_consent
throughout 115 125 5307 5317 O
treatment 126 135 5318 5327 B-treatment
and 136 139 5328 5331 O
for 140 143 5332 5335 O
at 144 146 5336 5338 O
least 147 152 5339 5344 O
8 153 154 5345 5346 B-lower_bound
weeks 155 160 5347 5352 I-lower_bound
after 161 166 5353 5358 O
T 167 168 5359 5360 B-treatment
cell 169 173 5361 5365 I-treatment
infusion 174 182 5366 5374 I-treatment

Research 0 8 5375 5383 O
participants 9 21 5384 5396 O
who 22 25 5397 5400 O
have 26 30 5401 5405 O
tested 31 37 5406 5412 O
human 38 43 5413 5418 B-chronic_disease
immunodeficiency 44 60 5419 5435 I-chronic_disease
virus 61 66 5436 5441 I-chronic_disease
( 67 68 5442 5443 I-chronic_disease
HIV 68 71 5443 5446 I-chronic_disease
) 71 72 5446 5447 I-chronic_disease
positive 73 81 5448 5456 O
, 81 82 5456 5457 O
or 83 85 5458 5460 O
have 86 90 5461 5465 O
active 91 97 5466 5472 O
hepatitis 98 107 5473 5482 B-chronic_disease
B 108 109 5483 5484 I-chronic_disease
or 110 112 5485 5487 I-chronic_disease
C 113 114 5488 5489 I-chronic_disease
infection 115 124 5490 5499 I-chronic_disease
based 125 130 5500 5505 O
on 131 133 5506 5508 O
testing 134 141 5509 5516 O
performed 142 151 5517 5526 O
within 152 158 5527 5533 O
4 159 160 5534 5535 B-upper_bound
weeks 161 166 5536 5541 I-upper_bound
of 167 169 5542 5544 O
enrollment 170 180 5545 5555 O

Research 0 8 5556 5564 O
participants 9 21 5565 5577 O
with 22 26 5578 5582 O
a 27 28 5583 5584 O
response 29 37 5585 5593 O
less 38 42 5594 5598 O
than 43 47 5599 5603 O
a 48 49 5604 5605 O
CR 50 52 5606 5608 O
or 53 55 5609 5611 O
complete 56 64 5612 5620 O
response 65 73 5621 5629 O
with 74 78 5630 5634 O
incomplete 79 89 5635 5645 B-treatment
hematopoietic 90 103 5646 5659 I-treatment
recovery 104 112 5660 5668 I-treatment
( 113 114 5669 5670 I-treatment
CRi 114 117 5670 5673 I-treatment
) 117 118 5673 5674 I-treatment
or 119 121 5675 5677 O
detectable 122 132 5678 5688 O
minimal 133 140 5689 5696 B-chronic_disease
residual 141 149 5697 5705 I-chronic_disease
disease 150 157 5706 5713 I-chronic_disease
( 158 159 5714 5715 I-chronic_disease
MRD 159 162 5715 5718 I-chronic_disease
) 162 163 5718 5719 I-chronic_disease
positive 164 172 5720 5728 O
disease 173 180 5729 5736 O

Research 0 8 5737 5745 O
participants 9 21 5746 5758 O
with 22 26 5759 5763 O
presence 27 35 5764 5772 O
of 36 38 5773 5775 O
other 39 44 5776 5781 O
active 45 51 5782 5788 O
malignancy 52 62 5789 5799 B-cancer

Research 0 8 5800 5808 O
participants 9 21 5809 5821 O
with 22 26 5822 5826 O
uncontrolled 27 39 5827 5839 O
intercurrent 40 52 5840 5852 O
illness 53 60 5853 5860 O
including 61 70 5861 5870 O
, 70 71 5870 5871 O
but 72 75 5872 5875 O
not 76 79 5876 5879 O
limited 80 87 5880 5887 O
to 88 90 5888 5890 O
ongoing 91 98 5891 5898 O
or 99 101 5899 5901 O
active 102 108 5902 5908 O
or 109 111 5909 5911 O
poorly 112 118 5912 5918 O
controlled 119 129 5919 5929 O
infection 130 139 5930 5939 B-chronic_disease
, 139 140 5939 5940 O
symptomatic 141 152 5941 5952 O
congestive 153 163 5953 5963 B-chronic_disease
heart 164 169 5964 5969 I-chronic_disease
failure 170 177 5970 5977 I-chronic_disease
, 177 178 5977 5978 O
unstable 179 187 5979 5987 B-chronic_disease
angina 188 194 5988 5994 I-chronic_disease
pectoris 195 203 5995 6003 I-chronic_disease
, 203 204 6003 6004 O
cardiac 205 212 6005 6012 B-chronic_disease
arrhythmia 213 223 6013 6023 I-chronic_disease
, 223 224 6023 6024 O
poorly 225 231 6025 6031 O
controlled 232 242 6032 6042 O
pulmonary 243 252 6043 6052 B-chronic_disease
disease 253 260 6053 6060 I-chronic_disease
or 261 263 6061 6063 O
psychiatric 264 275 6064 6075 B-chronic_disease
illness 276 283 6076 6083 I-chronic_disease
/ 283 284 6083 6084 I-chronic_disease
social 284 290 6084 6090 I-chronic_disease
situations 291 301 6091 6101 I-chronic_disease
that 302 306 6102 6106 O
would 307 312 6107 6112 O
limit 313 318 6113 6118 O
compliance 319 329 6119 6129 O
with 330 334 6130 6134 O
study 335 340 6135 6140 O
requirements 341 353 6141 6153 O

Research 0 8 6154 6162 O
participants 9 21 6163 6175 O
' 21 22 6175 6176 O
last 23 27 6177 6181 O
dose 28 32 6182 6186 O
of 33 35 6187 6189 O
prior 36 41 6190 6195 O
chemotherapy 42 54 6196 6208 B-treatment
or 55 57 6209 6211 O
radiation 58 67 6212 6221 B-treatment
must 68 72 6222 6226 O
be 73 75 6227 6229 O
> 76 77 6230 6231 O
= 77 78 6231 6232 O
2 79 80 6233 6234 B-lower_bound
weeks 81 86 6235 6240 I-lower_bound
before 87 93 6241 6247 I-lower_bound
leukapheresis 94 107 6248 6261 B-treatment

Research 0 8 6262 6270 O
patients 9 17 6271 6279 O
enrolled 18 26 6280 6288 O
are 27 30 6289 6292 O
those 31 36 6293 6298 O
patients 37 45 6299 6307 O
with 46 50 6308 6312 O
relapsed 51 59 6313 6321 O
or 60 62 6322 6324 O
refractory 63 73 6325 6335 O
CD123 74 79 6336 6341 O
+ 79 80 6341 6342 O
AML 81 84 6343 6346 B-cancer
de 85 87 6347 6349 O
novo 88 92 6350 6354 O
, 92 93 6354 6355 O
or 94 96 6356 6358 O
secondary 97 106 6359 6368 O
OR 107 109 6369 6371 O
participants 110 122 6372 6384 O
who 123 126 6385 6388 O
are 127 130 6389 6392 O
at 131 133 6393 6395 O
high 134 138 6396 6400 O
risk 139 143 6401 6405 O
for 144 147 6406 6409 O
disease 148 155 6410 6417 O
recurrence 156 166 6418 6428 O

Serum 0 5 6429 6434 B-clinical_variable
bilirubin 6 15 6435 6444 I-clinical_variable
= 16 17 6445 6446 O
< 17 18 6446 6447 O
3.0 19 22 6448 6451 B-upper_bound
mg 23 25 6452 6454 I-upper_bound
/ 25 26 6454 6455 I-upper_bound
dL 26 28 6455 6457 I-upper_bound

Women 0 5 6458 6463 B-gender
of 6 8 6464 6466 O
child 9 14 6467 6472 O
- 14 15 6472 6473 O
bearing 15 22 6473 6480 O
potential 23 32 6481 6490 O
and 33 36 6491 6494 O
men 37 40 6495 6498 O
must 41 45 6499 6503 O
agree 46 51 6504 6509 B-contraception_consent
to 52 54 6510 6512 I-contraception_consent
use 55 58 6513 6516 I-contraception_consent
adequate 59 67 6517 6525 I-contraception_consent
contraception 68 81 6526 6539 I-contraception_consent
( 82 83 6540 6541 O
hormonal 83 91 6541 6549 B-contraception_consent
or 92 94 6550 6552 O
barrier 95 102 6553 6560 B-contraception_consent
method 103 109 6561 6567 I-contraception_consent
of 110 112 6568 6570 I-contraception_consent
birth 113 118 6571 6576 I-contraception_consent
control 119 126 6577 6584 I-contraception_consent
or 127 129 6585 6587 O
abstinence 130 140 6588 6598 B-contraception_consent
) 140 141 6598 6599 O
prior 142 147 6600 6605 O
to 148 150 6606 6608 O
study 151 156 6609 6614 O
entry 157 162 6615 6620 O
and 163 166 6621 6624 O
for 167 170 6625 6628 O
six 171 174 6629 6632 B-upper_bound
months 175 181 6633 6639 I-upper_bound
following 182 191 6640 6649 O
duration 192 200 6650 6658 O
of 201 203 6659 6661 O
study 204 209 6662 6667 O
participation 210 223 6668 6681 O

all 0 3 6682 6685 O
participants 4 16 6686 6698 O
must 17 21 6699 6703 O
be 22 24 6704 6706 O
able 25 29 6707 6711 O
to 30 32 6712 6714 O
reduce 33 39 6715 6721 O
steroid 40 47 6722 6729 B-treatment
requirement 48 59 6730 6741 O
to 60 62 6742 6744 O
no 63 65 6745 6747 O
more 66 70 6748 6752 O
than 71 75 6753 6757 O
physiological 76 89 6758 6771 O
replacement 90 101 6772 6783 O
doses 102 107 6784 6789 O
prior 108 113 6790 6795 O
to 114 116 6796 6798 O
start 117 122 6799 6804 O
of 123 125 6805 6807 O
lymphodepletion 126 141 6808 6823 B-treatment

for 0 3 6824 6827 O
patients 4 12 6828 6836 O
with 13 17 6837 6841 O
AML 18 21 6842 6845 B-cancer
evolving 22 30 6846 6854 O
from 31 35 6855 6859 O
myelodysplastic 36 51 6860 6875 B-cancer
syndrome 52 60 6876 6884 I-cancer
, 60 61 6884 6885 O
they 62 66 6886 6890 O
should 67 73 6891 6897 O
have 74 78 6898 6902 O
completed 79 88 6903 6912 O
at 89 91 6913 6915 O
least 92 97 6916 6921 O
one 98 101 6922 6925 B-lower_bound
cycle 102 107 6926 6931 O
of 108 110 6932 6934 O
induction 111 120 6935 6944 B-treatment
chemotherapy 121 133 6945 6957 I-treatment

for 0 3 6958 6961 O
research 4 12 6962 6970 O
participants 13 25 6971 6983 O
who 26 29 6984 6987 O
are 30 33 6988 6991 O
at 34 36 6992 6994 O
a 37 38 6995 6996 O
high 39 43 6997 7001 O
risk 44 48 7002 7006 O
of 49 51 7007 7009 O
recurrence 52 62 7010 7020 O
, 62 63 7020 7021 O
they 64 68 7022 7026 O
must 69 73 7027 7031 O
have 74 78 7032 7036 O
historical 79 89 7037 7047 O
bone 90 94 7048 7052 O
marrow 95 101 7053 7059 O
and/or 102 108 7060 7066 O
peripheral 109 119 7067 7077 O
blood 120 125 7078 7083 O
samples 126 133 7084 7091 O
available 134 143 7092 7101 O
for 144 147 7102 7105 O
confirmation 148 160 7106 7118 O
of 161 163 7119 7121 O
diagnosis 164 173 7122 7131 O
of 174 176 7132 7134 O
AML 177 180 7135 7138 B-cancer
or 181 183 7139 7141 O
BPDCN 184 189 7142 7147 B-cancer

in 0 2 7148 7150 O
the 3 6 7151 7154 O
case 7 11 7155 7159 O
of 12 14 7160 7162 O
a 15 16 7163 7164 O
positive 17 25 7165 7173 O
hepatitis 26 35 7174 7183 B-treatment
C 36 37 7184 7185 I-treatment
antibody 38 46 7186 7194 I-treatment
result 47 53 7195 7201 O
, 53 54 7201 7202 O
the 55 58 7203 7206 O
hepatitis 59 68 7207 7216 B-chronic_disease
C 69 70 7217 7218 I-chronic_disease
virus 71 76 7219 7224 I-chronic_disease
( 77 78 7225 7226 I-chronic_disease
HCV 78 81 7226 7229 I-chronic_disease
) 81 82 7229 7230 I-chronic_disease
viral 83 88 7231 7236 O
polymerase 89 99 7237 7247 B-treatment
chain 100 105 7248 7253 I-treatment
reaction 106 114 7254 7262 I-treatment
( 115 116 7263 7264 I-treatment
PCR 116 119 7264 7267 I-treatment
) 119 120 7267 7268 I-treatment
will 121 125 7269 7273 O
have 126 130 7274 7278 O
to 131 133 7279 7281 O
be 134 136 7282 7284 O
performed 137 146 7285 7294 O
and 147 150 7295 7298 O
the 151 154 7299 7302 O
results 155 162 7303 7310 O
should 163 169 7311 7317 O
be 170 172 7318 7320 O
negative 173 181 7321 7329 O

lactating 0 9 7330 7339 O
women 10 15 7340 7345 B-gender

life 0 4 7346 7350 B-clinical_variable
expectancy 5 15 7351 7361 I-clinical_variable
> 16 17 7362 7363 O
= 17 18 7363 7364 O
16 19 21 7365 7367 B-lower_bound
weeks 22 27 7368 7373 I-lower_bound
at 28 30 7374 7376 O
time 31 35 7377 7381 O
of 36 38 7382 7384 O
enrollment 39 49 7385 7395 O

lymphodepleting 0 15 7396 7411 B-treatment
regimens 16 24 7412 7420 I-treatment
, 24 25 7420 7421 O
at 26 28 7422 7424 O
least 29 34 7425 7430 O
7 35 36 7431 7432 B-lower_bound
days 37 41 7433 7437 I-lower_bound
prior 42 47 7438 7443 I-lower_bound
to 48 50 7444 7446 O
CAR 51 54 7447 7450 B-treatment
T 55 56 7451 7452 I-treatment
cell 57 61 7453 7457 I-treatment
infusion 62 70 7458 7466 I-treatment

prednisone 0 10 7467 7477 B-treatment
no 11 13 7478 7480 O
more 14 18 7481 7485 O
than 19 23 7486 7490 O
7.5 24 27 7491 7494 B-upper_bound
mg 28 30 7495 7497 I-upper_bound
, 30 31 7497 7498 O
hydrocortisone 32 46 7499 7513 B-treatment
less 47 51 7514 7518 O
than 52 56 7519 7523 O
12 57 59 7524 7526 B-upper_bound
mg 60 62 7527 7529 I-upper_bound
/ 62 63 7529 7530 I-upper_bound
m^2 63 66 7530 7533 I-upper_bound
/ 66 67 7533 7534 I-upper_bound
day 67 70 7534 7537 I-upper_bound

research 0 8 7538 7546 O
participants 9 21 7547 7559 O
with 22 26 7560 7564 O
history 27 34 7565 7572 O
of 35 37 7573 7575 O
prior 38 43 7576 7581 O
malignancy 44 54 7582 7592 B-cancer
treated 55 62 7593 7600 O
with 63 67 7601 7605 O
curative 68 76 7606 7614 B-treatment
intent 77 83 7615 7621 I-treatment
and 84 87 7622 7625 O
in 88 90 7626 7628 O
complete 91 99 7629 7637 O
remission 100 109 7638 7647 O

